Omicron: Pharmaceutical firms say they can tweak vaccines to fight new strain
Major pharmaceutical firms around the world have said that work is being done to adapt their various vaccines to the new strain of Covid-19, Omicron, which has been designated a “variant of concern” by the WHO. AstraZeneca has said it is already testing its antibody combination drug against the new variant and is “hopeful” it “will retain efficacy since it comprises two potent antibodies with different and complementary activities against the virus”. Read more on this topic: https://www.independent.co.uk/news/uk/politics/omicron-covid-variant-vaccines-pollard-b1965208.html Like us on Facebook: https://www.facebook.com/TheIndependentOnline Follow us on Twitter: https://twitter.com/Independent Follow us on Instagram: https://www.instagram.com/the.independent Subscribe to Independent Premium for exclusive content and live events: https://bit.ly/2MiOONB
